Pulse pressure in the young population detected by ABPM and it’s relation to metabolic and anthropometric parameters

Česká verzia

Authors: J. Pařenica ¹; L. Pinková ²; O. Ludka ¹; P. Fráňa ²; H. Němcová ² ; J. Špinar ¹
Authors place of work: Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc. ¹; II. interní klinika Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc. ²
Published in the journal: Vnitř Lék 2005; 51(2): 167-174
Category: Original Contributions

Summary

Elevated value of pulse pressure (PP) is a predictor of increased cardiovascular mortality and morbidity. Ambulatory twenty four hour blood pressure monitoring (ABPM) shows a close correlation with end organ damage comparing with office blood pressure. The aim of this trial was to determine mean values of PP detected by ABPM in population aged 18–30 years, to determine variability of PP during day, to determine correlation between PP and systolic and diastolic blood pressure, heart rate and some risk factors of atherosclerosis. We have examined 252 probands (average age 23.6 ± 3.8, 55.2% were women). In this study the men population had significantly higher value of PP compare with women (53.4 ± 6.2 mm Hg vs 45.5 ± 4.5 mm Hg, p < 0.01). There was not different between ABPM and office value of PP. During day there was minimal variability of PP. The value of PP correlated with systolic but no with diastolic BP (correlation coefficient of PP and systolic blood pressure r = 0.62 for young men, r = 0.59 for young women, both p < 0.01). We have found inversion correlation of PP and HDL (r = –0.22, p < 0.05) for men and correlation of PP and BMI, waist circumference and waist-hip ratio for women on the border of statistical significance.

Key words:
pulse pressure – ambulatory twenty four hour blood pressure monitoring – young population

Zdroje

1. Benetos A, Safar M, Rudnichi A et al. Pulse pressure, a predictor of long term cardiovascular mortality in a french male population. Hypertension 1997; 30: 1410–1415.

2. Benetos A, Rudnichi A, Safar M et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560–564.

3. Cushman WC, Materson BJ, Williams DW et al. Pulse pressure Changes with six classes of antihypertensive agents in randomized, controlled trial. Hypertension 2001; 38: 953–957.

4. Dart AM, Kingwell BA. Pulse pressure– a review of mechanism and clinical relevance. J Am Coll Cardiol 2001; 37: 975–984.

5. Dart AM, Lacombe F, Yeoh JK et al. Aortic distensibility in patients with isolated hypercholesterolemia, coronary artery disease or cardiac transplant. Lancet 1991; 338: 270–273.

6. Domanski M, Mitchell G, Pfeffer M et al. Pulse pressure and cardiovascular disease-related mortality. Follw-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002; 287: 2677–2683.

7. Franklin S, Gustin W, Wong A et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96(1): 308–315.

8. Gasowski J, Fagard RH, Staessen JA et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trials control groups. J Hypertens 2002; 20(1): 145–151.

9. Horký K, Widimský J sr, Cífková R et al. Doporučení diagnostických a léčebných postupů u arteriální hypertenze – verze 2000. Vnitř Lék 2000; 46(Suppl 1): S5–S13.

10. Imai Y, Nagai K, Sakuma M et al. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 1993; 22: 900–912.

11. Kostis JB, Lawrence-Nelson J, Ranjan R et al. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens 2001; 14: 798–803.

12. Mancia G, Zanchetti A, Agebiti-Rosei E et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95(6): 1464–1470.

13. Millar AJ, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertension 1999; 17: 1065–1072.

14. Musso NR, Vergassola C, De Iorgi V et al. Pulse pressure in normotensive and hypertensive patients. Average values, relationships and differences by ambulatory blood pressure monitoring in 1940 subjects. Am J Hypertens 2001; 14(sup 1): A32.

15. Parati G, Pomidossi G, Albini F et al. Relationship of 24-hour blood pressure mean and variability to severity of targetorgan damage in hypertension. J Hypertension 1987; 5: 93–98.

16. Pařenica J, Kala P, Polozcek M et al. Stupeň postižení koronárních tepen souvisí s hodnotou pulsního tlaku. Cor Vasa 2003; 45(10): 160.

17. Pařenica J, Kubecová L, Špinar J et al. Ambulantní monitorování krevního tlaku u mladé populace. Vnitř Lék 2001; 47(12): 856–862.

18. Souček M, Kára T et al. Klinická patofyziologie hypertenze. Praha: Grada 2002.

19. Staessen J, Bieniaszewski L, O’Brien ET et al. What is a normal blood pressure on ambulatory monitoring? Nephrol Dial Transplant 1996; 11: 241–245.

20. Staessen J, O’Brien E, Atkins N et al. The increase in blood pressure with age and body mass index is overestimated by conventional sphygmomanometry. Am J Epidemiol 1992; 136: 450–459.

21. Škulec R, Petr P, Matznerová Z et al. 24hodinové ambulantní monitorování krevního tlaku. Vnitř Lék 2000; 1: 37–44.

22. Špinar J, Vítovec J, Zicha J. Hypertenze- diagnostika a léčba. Praha: Grada 1999.

23. Špinar J, Vítovec J. MORE-Moexipril a Regrese hypertrofie levé komory v kombinační léčbě. Multicentrická, otevřená klinická studie. Cor et Vasa 2003; 45(4): 212–220.

24. Verdecchia P, Porcellati C, Schillaci G et al. Ambulatory blood pressure an independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801.

25. Verdecchia P, Schillaci G, Borgioni C et al. Ambulatory pulse pressure, a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983–988.

26. Verdecchia P, Schillaci G, Reboldi G et al. Different prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001; 103(21): 2579–2584.

27. Vítovec J, Špinar J. Farmakoterapie kardiovaskulárních onemocnění. Praha: Grada 2000.

28. Vos LE, Oren A, Uiterwaal I et al. Adolescent blood pressure and blood pressure tracking into young adulthood are related to subclinical atherosclerosis: The atherosclerosis risk in young adults (ARYA) study. Am J Hypertens 2003; 16: 549–555.

29. Widimský J. Kardiovaskulární orgánové projevy esenciální hypertenze – možnosti cílené léčby a prevence. Vnitř Lék 1995; 41(6): 403–410.

30. Zakopoulos NA, Lekakis JP, Papamichael CM et al. Pulse pressure in normotensives: a marker of cardiovascular disease. Am J Hypertens 2001; 14(3): 195–199.

31. Zanchetti A. for the guidelines committee: 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003; 21: 1011–1023.